<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:protege="http://protege.stanford.edu/plugins/owl/protege#" xmlns:xsp="http://www.owl-ontologies.com/2005/08/07/xsp.owl#" xmlns:Thesaurus="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>BMC Developmental Biology                                                                                                                BioMed Central <br />  <br />  <br />  <br /> Research article                                                                                                                       Open Access <br /> Role 2 zebrafish survivin genes vasculo-angiogenesis, <br /> neurogenesis, cardiogenesis hematopoiesis <br /> Mieke Delvaeye, Astrid De Vriese, Femke Zwerts, Inge Betz, Michael Moons, <br /> Monica Autiero Edward M Conway* <br />  <br /> Address: KU Leuven, VIB Vesalius Research Center (VRC), Gasthuisberg O&amp;N-1, Herestraat 49, 3000 Leuven, Belgium <br /> Email: Mieke Delvaeye - Mieke.Delvaeye@vib-kuleuven.be ; Astrid De Vriese - Astrid.DeVriese@vib-kuleuven.be; <br /> Femke Zwerts - FemkeZwerts@yahoo.com; Inge Betz - Inge_Betz@yahoo.com; Michael Moons - Michael.Moons@vib-kuleuven.be; <br /> Monica Autiero - fb238607@skynet.be; Edward M Conway* - Ed.Conway@vib-kuleuven.be <br /> * Corresponding author <br />  <br />  <br />  <br />  <br /> Published: 26 March 2009                                                      Received: 15 November 2008 <br />                                                                               Accepted: 26 March 2009 <br /> BMC Developmental Biology 2009, 9:25   doi:10.1186/1471-213X-9-25 <br /> This article available <span id='am-2' about='protege:FROM' typeof='owl:Thing'>from</span>: http://www.biomedcentral.com/1471-213X/9/25 <br /> &#194;&#169; 2009 Delvaeye et al; licensee BioMed Central Ltd. <br /> This Open Access article distributed terms Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), <br /> which permits unrestricted use, distribution, reproduction medium, provided original work properly cited. <br />  <br />  <br />  <br />  <br />                  <span id='am-1' about='protege:abstract' typeof='owl:Thing'>Abstract</span> <br />                  Background: Normal growth development organisms requires maintenance dynamic <br />                  balance systems promote cell <span id='am-5' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-6' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-7' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-8' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-9' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-10' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-11' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-12' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-13' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-14' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-15' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-16' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-17' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-18' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-19' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-20' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-21' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-22' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-23' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-24' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-25' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-26' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-27' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-28' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-29' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-30' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-31' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-32' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-33' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-34' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-35' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-36' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-37' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-38' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-39' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-40' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-41' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-42' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-43' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-44' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-45' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-46' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-47' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-48' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-49' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-50' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-51' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-52' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-53' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-54' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-55' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-56' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-57' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-58' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-59' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-60' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-61' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-62' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-63' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-64' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-65' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-66' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-67' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-68' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-69' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-70' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-71' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-72' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-73' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-74' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-75' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-76' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-77' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-78' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-79' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-80' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-81' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-82' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span>survival</span> induce apoptosis. The molecular <br />                  mechanisms regulate processes remain poorly understood, vivo study <br />                  required. Survivin member inhibitor apoptosis protein (IAP) family, uniquely <br />                  promotes mitosis cell proliferation. Postnatally, survivin hardly detected tissues, <br />                  upregulated cancers, such, potential therapeutic target. Prenatally, survivin is <br />                  highly expressed tissues. Fully delineating properties survivin vivo mice <br />                  confounded early lethal phenotypes following survivin gene inactivation. <br />                  Results: <span id='am-4' about='protege:TO' typeof='owl:Thing'>To</span> gain insights properties survivin, used zebrafish model. <br />                  There 2 zebrafish survivin genes (Birc5a Birc5b) overlapping expression patterns during <br />                  early development, prominently neural vascular structures. Morpholino-induced depletion <br />                  Birc5a causes profound neuro-developmental, hematopoietic, cardiogenic, vasculogenic and <br />                  angiogenic defects. Similar abnormalities, severe hematopoiesis, evident <br />                  suppression Birc5b. The phenotypes induced morpholino knockdown survivin <br />                  gene, rescued overexpression other, indicating Birc5 paralogs may <br />                  compensate each. The potent vascular endothelial growth factor (VEGF) entirely rescues <br />                  phenotypes induced depletion Birc5a Birc5b, highlighting multi-functional <br />                  properties, power model characterizing activities growth factors. <br />                  Conclusion: Overall, zebrafish model, identify survivin key regulator of <br />                  neurogenesis, vasculo-angiogenesis, hematopoiesis cardiogenesis. These properties survivin, <br />                  consistent identified mice, indicate functions highly conserved <br />                  species, point value zebrafish model understanding role IAP <br />                  pathogenesis human disease, exploring potential therapeutic target. <br />  <br />  <br />  <br />  <br />                                                                                                                                        Page 1 17 <br />                                                                                                                  (page number citation purposes) <br />  BMC Developmental Biology 2009, 9:25                                          http://www.biomedcentral.com/1471-213X/9/25 <br />  <br />  <br />  <br />  <br /> Background                                                      To gain insights developmental role of <br /> For normal homeostasis multicellular organisms,        survivin, used zebrafish model detailed the <br /> exists delicate balance cell proliferation cell   spatio-temporal expression patterns 2 survivin genes <br /> death, maintenance required prevent path-        characterized functions. Zebrafish survivin 1 <br /> ological outcomes including developmental abnormali-            (Birc5a) survivin 2 (Birc5b) prevent apoptosis <br /> ties, cancer, autoimmune diseases, degenerative disorders       promote cell proliferation. While overlap- <br /> and poor outcome following wounds ischemic                  ping patterns distribution function, Birc5a pre- <br /> injury. The major physiologic means cell death         dominates systems. Consistent role the <br /> is achieved organism apoptosis, tightly regu-    mouse, zebrafish survivin genes play critical roles in <br /> lated highly conserved process. In spite major gains     regulating developmental vasculogenesis, angiogenesis, <br /> in characterizing apoptotic pathways vitro, better     neurogenesis, cardiogenesis, valvulogenesis hemat- <br /> understanding precise cellular mechanisms             opoiesis. The model highlights conservation sur- <br /> apoptosis different tissues developmental time           vivin&apos;s functions species, points the <br /> points vivo required.                               relevance utilizing zebrafish model evaluate its <br />                                                                 mechanisms action, findings extrapolated <br /> The inhibitor apoptosis proteins (IAPs) family      human disease. <br /> conserved caspase inhibitors originally identified bacu- <br /> loviruses proteins capable preventing virus-mediated      Results <br /> cell death insect cells. Survivin smallest     Orthologues Survivin zebrafish <br /> human inhibitor apoptosis proteins (IAPs),           A BLAST search orthologues human survivin in <br /> several unique features (reviewed [1]). It possesses     zebrafish revealed 2 survivin genes (Birc5a Birc5b) <br /> baculovirus IAP repeat (BIR) domain essential       located chromosomes 12 23, respectively. Using <br /> caspase interference, contains C-terminal alpha-hel-      CLUSTAL W program, putative predicted proteins <br /> ical coiled-coil domain [2] important mitosis.      aligned orthologous proteins in <br /> Survivin functions chromosome passenger protein,           human, mouse, Xenopus laevis Xenopus tropicalis <br /> complexing aurora B, borealin INCENP [3]. Sur-         (Additional file 1A). Human survivin 142 amino acids <br /> vivin promotes cell cycle progression [4],          long, comprised 15 amino acid N-terminal domain, a <br /> highly expressed proliferating cells, barely     BIR domain (amino acids 16&#226;&#8364;&#8220;87), C-terminal <br /> detectable quiescent adult tissues [5]. Its uniformly ele-   coiled-coil domain. The proteins encoded Birc5a and <br /> vated expression essentially cancers rendered        Birc5b exhibit 45&#226;&#8364;&#8220;55% overall similarity from <br /> survivin therapeutic target (reviewed [6,7]),     species (Additional file 1B). The <br /> a critical understanding properties survivin key   greatest sequence conservation Birc5a Birc5b <br /> for successful introduction clinic.                resides BIR domain (79% similarity). From compu- <br />                                                                 ter analysis (COILS: http://www.ch.EMBnet.org/software/ <br /> In humans mice, single survivin gene        COILS_form.html), C-terminal domains the <br /> that generates different protein products        zebrafish survivin proteins form coiled-coil alpha- <br /> alternative pre-mRNA splicing (reviewed [8]). Trans-         helical structures, region murine survivin, inter- <br /> genic mouse studies revealed major, full-<span id='am-3' about='xsp:length' typeof='owl:Thing'>length</span>        acts mitotic spindle. <br /> form survivin crucial normal leukocyte [9] and <br /> hepatocyte function [10], hematopoiesis [11], opti-         Expression patterns Birc5a Birc5b <br /> mal angiogenic response injury [2,8,12]. Elucidating     Ma et al [16] previously described expression Birc5a in <br /> developmental role limited fact sur-       26 hpf zebrafish embryos restricted developing <br /> vivin gene inactivation mice causes early embryonic          brain, neural tube, cells surrounding axial ves- <br /> lethality [3,10]. Nonetheless, conditional gene inactiva-       sels. We performed detailed studies expression pat- <br /> tion studies indicate survivin essential brain      terns Birc5a Birc5b situ hybridization <br /> development [13], angiogenesis cardiogenesis [14].          using gene-specific probes (Additional file 2). The 2 genes <br /> In Xenopus laevis, 2 survivin genes, overexpression   entirely overlap spatio-temporal patterns expres- <br /> of induces endothelial proliferation [15],      sion. Since prior reports expression of <br /> augmented expression inexplicably lethal       Birc5b zebrafish embryo, provide <br /> effects. Danio rerio (zebrafish) 2 survivin genes.    images Birc5b (Figure 1). Birc5a Birc5b were <br /> Ma et al [16] reported survivin important angio-     detected maternal messages embryo 1 <br /> genesis zebrafish development, studies         hour post fertilization (hpf) (not shown). Similar the <br /> were limited, authors did examine early devel-       report Ma et al [16] Birc5a, 20&#226;&#8364;&#8220;24 hpf (20&#226;&#8364;&#8220;30 <br /> opmental time points, restricted analyses         somites), expression genes prominent neu- <br /> only genes, did evaluate            ral tissues, including entire brain, neural tube, floor <br /> importance survivin organ systems.                  plate, midbrain-hindbrain barrier (Figure 1A, B). In <br />  <br />                                                                                                                     Page 2 17 <br />                                                                                               (page number citation purposes) <br />  BMC Developmental Biology 2009, 9:25                                               http://www.biomedcentral.com/1471-213X/9/25 <br />  <br />  <br />  <br />  <br /> Birc5b <br /> Figurespatiotemporal <br />           1               expression zebrafish embryos <br /> Birc5b spatiotemporal expression zebrafish embryos. A, B. Lateral (A) dorsal (B) views 20 hpf (20 somites) <br /> embryos revealing expression Birc5b neural tube, brain, pronephric duct eyes. C. Lateral view 1 dpf (30 somites) <br /> embryo, showing Birc5b expression brain, eye, neural tube, somite intersomite boundaries, higher magnification in <br /> D. E. Transverse section 1 dpf embryo (from C), revealing expression Birc5b neural tube, somites caudal vein <br /> plexus. F. Dorsal view head region 2 dpf embryo. Birc5a detected brain, floor plate branchial arches. G. Diagram of <br /> 2 dpf embryo transverse sections panels H I. Transverse sections 2 dpf embryo reveals expression ret- <br /> ina iris (H), floor plate, dorsal aorta, posterior cardinal vein; somite (I). J-L. Lateral (J) dorsal (K, L) views 3 <br /> dpf embryo; expression Birc5b midbrain-hindbrain barrier, branchial arches eyes; region axial vessels, somites <br /> or intersomite boundaries (L). nt: neural tube, p: pronephric duct, b: brain, e: eye, rt: retina, I: iris, mh: midbrain-hindbrain bar- <br /> rier, fp: floor plate, ba: branchial arches, s: somite, sb: intersomite boundary, da: dorsal aorta, pcv: posterior cardinal vein, cv: <br /> caudal vein plexus. <br />  <br />  <br />  <br />  <br />                                                                                                                            Page 3 17 <br />                                                                                                      (page number citation purposes) <br />  BMC Developmental Biology 2009, 9:25                                          http://www.biomedcentral.com/1471-213X/9/25 <br />  <br />  <br />  <br /> contrast report Ma et al, 1 dpf,      situ hybridization probes detect Zic1, pan- <br /> Birc5 expression ventral somites, somite           neural marker [20] (Figure 2G&#226;&#8364;&#8220;I), Islet1, marker of <br /> boundaries, caudal vein plexus, eye        primary motor neurons [21] (Figure 2J&#226;&#8364;&#8220;L). Zic1 staining <br /> (Figure 1B&#226;&#8364;&#8220;E). Although evident 20 hpf, 2 dpf,           brain decreased 2 dpf Birc5a morphants <br /> there prominent expression Birc5 tran-          compared controls, reflecting total <br /> scripts lens retina eyes, major axial   absence neural cells. The reduction evident in <br /> vessels, branchial arch primordia (Figure 1F&#226;&#8364;&#8220;I).      Birc5b morphants, lesser extent compared to <br /> Notably, 2 dpf, expression somites          Birc5a morphant. Similarly, islet1 staining the <br /> absent (Figure 1I). By 3 dpf, Birc5 transcripts        Birc5a morphants revealed disorganized absent motor <br /> detected branchial arches, brain, mid-      neurons, Birc5b morphants affected, <br /> brain-hindbrain boundary, eyes,            again, severely. <br /> entirely absent axial vessels somites (Figure 1J&#226;&#8364;&#8220; <br /> L). Overall, expression patterns zebrafish sur-   Overall, Birc5 genes critical normal neural <br /> vivin genes indistinguishable development,        development, Birc5a predominating. <br /> are predominantly localized neural, vascular ocular <br /> structures, transient expression somites         Birc5 vasculogenesis angiogenesis <br /> axial vessels formation.                            Recently, Ma et al [16] reported Birc5a knockdowns <br />                                                                  primarily induce angiogenic abnormalities, without <br /> Zebrafish Birc5 morpholino knockdowns                            affecting vasculogenesis. We extended work by <br /> To assess functions Birc5a Birc5b, used mor-       examining vasculo-angiogenesis Birc5a Birc5b <br /> pholinos knock genes. Morpholinos            knockdown embryos different developmental time <br /> were selected target sites orthologue        points, using Tg(Fli:eGFP) Tg(Flk1:GFP) embryos <br /> the sequence divergence, including start codon          (Zebrafish International Resource Center [22]) which <br /> (ATG morpholinos). Specificity ATG morpholinos            express green fluorescent protein (GFP) endothelial <br /> confirmed using morpholinos target pre-             cells (Figure 3). <br /> mRNA splice sites 5&apos; UTR regions (Additional file 3). <br /> Controls performed injecting mismatch mor-             Precursor angioblasts zebrafish arise 12 hpf (6 <br /> pholino (GeneTools, Philomath, Oregon, USA). Each                somites) lateral plate mesoderm migrate from <br /> morpholino dose tested 100 embryos. All          14 hpf (10 somites) midline, coa- <br /> morpholinos (ATG, splice site UTR) gene gave         lesce form primary axial vessels [22]. We estab- <br /> identical phenotypes; results reported reflect         lished depletion Birc5a Birc5b does induce a <br /> with ATG-morpholinos. We additionally confirmed gene-            defect mesodermal development, determining that <br /> specificity vitro transcription-translation studies.       expression mesodermal marker, tail (ntl) [23] in <br /> Even high doses, Birc5a morpholinos effect          morphants 6 hpf, compared control <br /> Birc5b expression, similarly, Birc5b morpholinos did         zebrafish embryos, different (not shown). <br /> not affect Birc5a expression (Additional file 4[17,18]). <br /> Finally, studies, excluded p53-mediated off-tar-       We studied effect depleting Birc5a Birc5b <br /> get effects apoptosis observed survivin mor-          highest morpholino doses (2 ng 4 ng, respec- <br /> pholino-induced phenotypes, co-injecting p53                  tively) vasculogenesis angiogenesis. At 16 hpf (14 <br /> morpholinos, described [19] (data shown).                 somites), Birc5a morphant angioblasts migrated disor- <br />                                                                  ganized fashion, different rates, remaining at <br /> Birc5 neural development                                      lateral plate mesoderm (Figure 3A, B). Angioblasts in <br /> Birc5a Birc5b morpholino-injected wild-type AB               Birc5b morphants migrated normally midline 16 <br /> embryos assessed brightfield microscopy (Figure          hpf (Figure 3C), reduced signal intensity and <br /> 2). After injection 0.5 ng Birc5a morpholino, morphant        thickness coalescing axial vessels (22% embryos, n <br /> embryos 1 dpf (Fig 2A, B) 2 dpf (Fig 2D, E) dis-          = 147). With depletion Birc5a, dorsal aorta pos- <br /> played microcephaly (42%, n = 162 1 dpf; 57%, n = 157         terior cardinal vein 1 dpf 2 dpf thinner (45&#226;&#8364;&#8220; <br /> at 2 dpf) fluid accumulation 4th ventricle (Fig      52%), smaller caudal vein plexus (45&#226;&#8364;&#8220;52%) (Figure <br /> 2E). The effects Birc5b depletion brain development        3D, E, G, H, J, K). A similar effect, promi- <br /> using highest morpholino dose dramatic             nent involving posterior cardinal vein, also <br /> than Birc5a knockdown, 10&#226;&#8364;&#8220;15% Birc5b            evident Birc5b morphants (Figure 3F, I, L). The findings <br /> morphants exhibiting microcephaly 1 dpf (n = 143)             better visualized following situ hybridization 1 <br /> and 2 dpf (n = 105) (Figure 2C, F).                              dpf embryos probes flt4 gridlock (grl) detect <br />                                                                  posterior cardinal vein dorsal aorta/intersom- <br /> Disturbances neuronal development were, however,              itic vessels, respectively [24] (Figure 3M&#226;&#8364;&#8220;R). The Birc5a <br /> more readily detectable Birc5a Birc5b mutants        morphants exhibited delayed sprouting intersomitic <br />  <br />                                                                                                                     Page 4 17 <br />                                                                                               (page number citation purposes) <br />  BMC Developmental Biology 2009, 9:25                                             http://www.biomedcentral.com/1471-213X/9/25 <br />  <br />  <br />  <br />  <br /> Figure <br /> Birc5 neurodevelopment <br />          2 <br /> Birc5 neurodevelopment. Brightfield microscopy AB zebrafish embryos. A-F: Embryos oriented head left. Lat- <br /> eral views 1 dpf (A, B, C) 2 dpf (D, E, F), higher power views head region. Depletion Birc5a results <br /> in lack brain development, revealed 1 dpf (B, arrow) 2 dpf (E, arrow), fluid 4th ventricle, compared controls <br /> (A, D). At 2 dpf, Birc5a knockdown causes cardiogenic defects pericardial edema (E, double arrow), observed con- <br /> trols (D). Majority Birc5b depleted embryos exhibit phenotypic abnormalities brightfield microscopy 1 dpf <br /> (C) compared controls (A). At 2 dpf, Birc5b knockdown embryos smaller head brain, accumulate blood the <br /> sinus venosus (F, arrow). Zic1 expression detect neural tissue, decreased Birc5a depletion (H, arrow), compared to <br /> controls (G). A similar dramatic diminution Zic1 expression observed morpholino knockdown Birc5b (I, <br /> arrow). Depletion Birc5a induces disorganization motor neurons, detected expression islet1 (K, arrow), com- <br /> pared controls (J). Birc5b morphants exhibit severe evident, suppression islet1 expression (L, arrow). <br />  <br />  <br />  <br />                                                                                                                         Page 5 17 <br />                                                                                                   (page number citation purposes) <br />  BMC Developmental Biology 2009, 9:25                                         http://www.biomedcentral.com/1471-213X/9/25 <br />  <br />  <br />  <br /> vessels (ISVs), occasionally absent, other-      embryos, significantly reduced (p &lt; 0.01) deple- <br /> wise thin, misdirected, lacking connections,     tion Birc5a Birc5b. Overall, data support a <br /> associated interruption dorsal longitudinal         role Birc5 genes promoting hematopoiesis in <br /> anastomotic vessels. These findings, concert fact   developing zebrafish embryo. <br /> that Birc5 expression transiently detected somite <br /> boundaries, suggests role survivin ISV patterning      Birc5 cardiogenesis <br /> and vessel guidance (reviewed [25]). Interestingly    Depletion Birc5a Birc5b resulted cardiovas- <br /> contrast, formation intersomitic vessels dorsal      cular defects. At highest morpholino dose, third <br /> longitudinal anastomotic vessels remained intact         Birc5a morphants displayed pericardial edema, while <br /> Birc5b morphants.                                               blood flow dorsal aorta posterior cardinal vein <br />                                                                 slowed absent half embryos. The <br /> By 3 dpf, underdevelopment irregular pat-         heart rate Birc5a Birc5b morphants signif- <br /> terning cranial blood vessels Birc5a         icantly reduced (60 &#194;&#177; 8, 56 &#194;&#177; 8, 86 &#194;&#177; 7 beats/minute <br /> Birc5b morphants (see Additional Files 5, 6, 7) compared     Birc5a morphants, Birc5b morphants, controls, <br /> with controls. Only 1 branchial arches seen       respectively; p &lt; 0.001 versus controls). In situ hybridiza- <br /> the majority Birc5a morphants (61%) (Figure 3S, T),      tion 30 hpf ventricle cardiac-specific mark- <br /> while 5th 6th branchial arches Birc5b mor-       ers, ventricle myosin heavy chain (vmhc) cardiac <br /> phants absent hypoplastic (65%) (n = 160)        myosin light chain (cmlc2) [30], respectively, demon- <br /> (Figure 3U). In attempting explain branchial arch        strated Birc5a morphant ventricles hearts were <br /> defects, performed situ hybridization studies 2 dpf    smaller controls (41%, n = 24 vmhc; 42%, n = 76 <br /> with crestin, post migratory neural crest cell marker [26].   cmlc2) (Figure 5A, B, D, E). Although striking, <br /> In Birc5a Birc5b morphants,           Birc5b morphants exhibited smaller ventricles and <br /> prominent depletion Birc5a, fewer cres-      hearts 30 hpf (Figure 5C, F) (26%, n = 31 vmhc; <br /> tin-positive neural crest cells region neural     32%, n = 89 cmlc2). At 48 hpf atrio-ventricular <br /> crest, corresponding critical develop-     (a-v) valve formation underway, bone morphogenic <br /> ment branchial arches [27] (Figure 3V&#226;&#8364;&#8220;X).                protein 4 (bmp4) [31] transcripts progressively localize <br />                                                                 atrium ventricle myocardial cells the <br /> In summary, Birc5 genes important normal           valve-forming region [32]. With Birc5a depletion, redistri- <br /> vasculogenesis, angiogenesis, vascular patterning.          bution bmp4 did occur 38% (n = 62) embryos <br /> Although 2 genes functionally overlap, again, Birc5a        (Figure 5G, H), predicting defects valvulogenesis. This <br /> appears play prominent role.                          evident hematoxylin eosin (H&amp;E) stained sec- <br />                                                                 tions 4 dpf embryos, little evidence of <br /> Birc5 hematopoiesis                                          a-v valve Birc5a morphants, time the <br /> Since, zebrafish, subset hematopoietic     myocardial layer morphant ventricle thin- <br /> and endothelial lineages arise common heman-             ner, compared control embryos (Figure 5J, K). In the <br /> gioblast [28], examined Birc5a Birc5b mor-          Birc5b morphants, bmp4 localized a-v valve, <br /> phants defective hematopoiesis. Erythrocytes 3 dpf       similar controls, opening smaller in <br /> embryos identified staining hemoglobin         21% (n = 44) (Figure 5I). At 4 dpf, H&amp;E stained sections <br /> o-dianisidine. Depletion Birc5a Birc5b resulted      revealed smaller cardiac chambers (20%) (Figure 5L). <br /> reduced number erythrocytes ducts Cuvier <br /> (Figure 4A&#226;&#8364;&#8220;C). Moreover, gata1 expression, reflecting           Although diminished vascular perfusion contribute <br /> hematopoiesis 1 dpf, reduced 35% Birc5a            cardiogenic defects [33], hypothesized addi- <br /> morphants (n = 112), 28% Birc5b morphants (n =           tional factor Birc5 morphants altered for- <br /> 115), compared controls (n = 70) (Figure 4D&#226;&#8364;&#8220;F).           mation and/or migration cardiac neural crest cells, a <br /> Since defects circulation impact preceding        site origin cardiomyocytes zebrafish [34]. <br /> findings, examined hematopoiesis 14 hpf, prior         Embryos 15.5 hpf (13 somites) hybrid- <br /> development functional circulation. Flow cytometry         ized foxd3 probe stain premigratory neural <br /> of cellular suspensions dechorianated Tg(gata1:GFP)          crest cells [35]. Birc5a depletion caused cardiac neural <br /> embryos used quantify number Gata1+ cells         crest cell loss rostrocaudal axis (Figure 5M, N), <br /> relative total number cells [29]. Depletion        particularly region critical formation ven- <br /> either Birc5a Birc5b, compared control injections,     tricle, a-v junction, atrium (region referred as <br /> resulted decrease absolute number Gata1+         &quot;Group B&quot; Sato et al [36]). Birc5b depletion also <br /> cells 3.37% controls 0.72% Birc5a,       resulted loss cardiac neural crest cells &#226;&#8364;&#8220; again, as <br /> 0.42% Birc5b. In line findings, expression    dramatically Birc5a depletion (Figure 5O). <br /> hematopoietic genes gata1, scl Imo2 [29], quantified        Overall, findings indicate Birc5a- Birc5b- <br /> by real-time PCR 14 hpf 18 hpf AB zebrafish           dependent signals important maintaining integ- <br />  <br />                                                                                                                     Page 6 17 <br />                                                                                               (page number citation purposes) <br />  BMC Developmental Biology 2009, 9:25                                                 http://www.biomedcentral.com/1471-213X/9/25 <br />  <br />  <br />  <br />  <br /> Figure <br /> Birc5 vasculogenesis <br />          3              angiogenesis <br /> Birc5 vasculogenesis angiogenesis. Tg(Fli:eGFP) (A-L) Tg(Flk1:GFP) (S-U) embryos. A-C: 16 hpf (14 somites), <br /> Birc5a morphants angioblast migration defects lateral plate mesoderm (B) minor Birc5b morphants (C). <br /> D-F: 1 dpf, Birc5a (E, H) Birc5b (F, I) morphants thinner axial vessels poor caudal vein plexus development. G-I: 1 <br /> dpf Birc5a depletion (H) delays intersomitic vessels; Birc5b depletion (I). J-L: 2dpf Birc5a morphants abnormal dor- <br /> sal longitudinal anastomic intersomitic vessels. Both morphants poorly developed caudal vein plexus. M-O: flt4 1 <br /> dpf reduced posterior cardinal vein morphants (N, O). P-R: gridlock (grl) 1 dpf reduced Birc5a depletion <br /> (Q), Birc5b (R). S-U: 3 dpf Birc5a morphants hypoplastic aortic arches (T). Birc5b depletion 3 dpf causes <br /> hypoplasia aortic arches 5&#226;&#8364;&#8220;6 (U). V-X: Birc5a depletion decreases neural crest cells migrate branchial arches, <br /> detected crestin probe. Birc5b depletion (L) reduces neural crest cells. ax: axial vessels, mhc: midbrain-hindbrain channel, <br /> Se: intersomitic vessels, aa: aortic arch, cv: caudal vein plexus, pcv: posterior cardinal vein, da: dorsal aorta, dlav, dorsal longitu- <br /> dinal anastomic vessel, Ha: hypobranchial artery, va: ventral aorta, lpm: lateral plate mesoderm. <br />  <br />  <br />  <br />  <br />                                                                                                                             Page 7 17 <br />                                                                                                       (page number citation purposes) <br />  BMC Developmental Biology 2009, 9:25                                          http://www.biomedcentral.com/1471-213X/9/25 <br />  <br />  <br />  <br /> rity cardiac neural crest cells turn, contribute   apoptotic cells regions (p &lt; 0.05) (Figure 6J&#226;&#8364;&#8220;L). <br /> normal cardiogenesis valvulogenesis.                         However, Birc5a morpholino dose was <br />                                                                  decreased 0.5 ng, apoptosis caudal vein plexus <br /> Birc5 knockdowns result increased apoptosis               entirely resolved, TUNEL staining neural tube <br /> decreased cell proliferation                                     persisted (Figure 6M, N), indicating greater sensitivity of <br /> Ma et al [16] reported depletion Birc5a caused           neural structures loss Birc5a. Conversely, the <br /> increased apoptosis primarily neural tube             Birc5b morpholino dose decreased, effect the <br /> brain. Given diverse pro-survival properties sur-         neural tube diminished, apoptosis region of <br /> vivin, assessed mechanisms action              caudal vein plexus persisted (Figure 6M, O). <br /> zebrafish survivin gene neural vascular systems. <br />                                                                  We quantified effects genes cell pro- <br /> TUNEL staining normal Tg(Fli:eGFP) embryos 1 dpf           liferation (Figure 7). At 1 dpf, proliferating cells were <br /> (Figure 6, left column) 2 dpf (not shown) revealed           present region caudal vein plexus neural <br /> minimal evidence apoptosis. In contrast, mor-            tube (Figure 7A, B). Birc5a depletion using 2 ng mor- <br /> pholino dose 2 ng, Birc5a morphants exhibited signifi-        pholino interfered cell proliferation regions, <br /> cant apoptosis, brain spinal cord              0.5 ng dose (Figure 7D, E) suppressed pro- <br /> (Figure 6A, B, D, E), lesser amounts region       liferation neural tube. Depletion Birc5b inter- <br /> the axial vessels caudal vein plexus (Figure 6E, H).         fered cell proliferation caudal vein plexus and <br /> TUNEL staining Birc5b morphants 1 dpf was,          neural tube, anti-proliferative effect neural <br /> comparison, neural tissues, promi-          tube disappeared lower morpholino dose (Figure 7C, <br /> nent region caudal vein plexus axial ves-      F). Overall, findings support notion Birc5 <br /> sels (Figure 6C, F). With gene knockdowns,                  genes interfere apoptosis promote cell prolifera- <br /> apoptosis remained spatially unchanged,                  tion early zebrafish development, are <br /> increased 2 dpf (not shown).                                  dose-dependent site-specific distinguishing features. <br />  <br /> Quantification TUNEL positive cells caudal vein        <span id='am-161' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-162' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-163' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-164' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-165' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-166' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-167' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-168' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-169' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-170' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-171' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-172' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-173' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-174' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-175' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-176' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-177' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-178' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-179' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-180' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-181' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-182' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-183' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-184' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-185' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-186' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-187' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-188' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-189' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-190' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-191' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-192' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-193' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-194' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-195' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-196' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-197' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-198' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-199' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-200' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-201' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-202' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-203' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-204' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-205' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-206' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-207' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-208' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-209' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-210' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-211' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-212' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-213' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-214' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-215' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-216' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-217' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-218' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-219' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-220' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-221' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-222' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-223' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-224' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-225' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-226' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-227' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-228' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-229' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-230' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-231' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-232' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-233' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-234' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-235' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-236' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-237' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-238' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span>Phenotype</span> rescues Birc5a Birc5b morphants <br /> plexus corresponding dorsal neural tube region           We determined rescue Birc5 mor- <br /> confirmed depletion Birc5a Birc5b       phants co-injecting synthetic mRNAs encoding the <br /> higher dose, caused significant increase number      open reading frame Birc5a Birc5b. In dose- <br />  <br />  <br />  <br />  <br /> Figure <br /> Birc5 hematopoiesis <br />          4 <br /> Birc5 hematopoiesis. A-C: Depletion Birc5a (B) Birc5b (D) causes reduction erythropoiesis, shown staining of <br /> erthrocytes o-dianisidine (control, A). D-F: The preceding consistent decreased expression gata1 situ <br /> hybridization gene knockdowns (E, F) compared control (D). ccv: common cardinal vein duct Cuvier, o- <br /> dian.: o-dianisidine. <br />  <br />  <br />                                                                                                                      Page 8 17 <br />                                                                                                (page number citation purposes) <br />  BMC Developmental Biology 2009, 9:25                                             http://www.biomedcentral.com/1471-213X/9/25 <br />  <br />  <br />  <br />  <br /> Figure <br /> Birc5 cardiogenesis <br />          5 <br /> Birc5 cardiogenesis. In situ hybridizations (A-I, M-O) histologic sections (J-L) AB embryos. A-C: At 30 hpf, expres- <br /> sion cardiac ventricle marker vmhc reduced Birc5a depletion (A, B), lesser extent Birc5b morphants (C). D- <br /> F: cmlc2 staining shows Birc5a (E) Birc5b (F) morphants impaired development atrium ventricle, compared to <br /> controls (D). G-I: At 48 hpf, bmp4 normally localizes heart reveal ring-like structure, representing endocardial cushions <br /> of atrio-ventricular valve (G, arrow). With depletion Birc5a, bmp4 staining remains diffuse ring structure absent <br /> (H, arrow). In Birc5b-morphants, bmp4 localizes normally (I, arrow), ring smaller. J-L: H&amp;E stained histologic sections <br /> of hearts normal embryos (J), depleted Birc5a (K) Birc5b (L) 4 dpf. Birc5a morphants thin-walled <br /> heart chambers, little evidence a-v valve formation. Birc5b-depleted embryos smaller ventricles. M-O: Premigratory <br /> cardiac neural crest cells contributing heart development, detected staining embryos 15.5 hpf (13 somites) with <br /> foxd3. Compared controls (M), premigratory neural crest cells barely detectable embryos depleted Birc5a (N), <br /> and reduced Birc5b morphants (O). a:atrium, v:ventricle. <br />  <br />  <br />  <br />  <br />                                                                                                                         Page 9 17 <br />                                                                                                   (page number citation purposes) <br />  BMC Developmental Biology 2009, 9:25                                        http://www.biomedcentral.com/1471-213X/9/25 <br />  <br />  <br />  <br /> dependent manner, co-injection respective Birc5         larly profound developmental effects multiple organ <br /> mRNA entirely rescued vascular neu-        systems following gene inactivation knockdown in <br /> ral phenotypes induced highest morpholino dose          small animal models [38]. <br /> (Table 1). Thus, 2 dpf, Birc5a morphants res- <br /> cued co-injection 1 ng Birc5a mRNA,           Our findings consistent immunohistochemical <br /> Birc5b morphants rescued 1 ng Birc5b mRNA.          analyses survivin gene inactivation studies the <br /> Furthermore, co-injection 1 ng Birc5b mRNA         mouse embryo, single survivin gene essential <br /> also partially rescue Birc5a morphants, Birc5b       survival, plays key role angiogenesis, neu- <br /> morphants completely rescued Birc5a mRNA.          rogenesis, cardiogenesis hematopoiesis [5,11,13,14]. <br /> The findings indicate 2 survivin genes may,     Our studies support concept the <br /> different conditions, compensate other.               zebrafish paralogs, Birc5a Birc5b, largely recapitulate <br />                                                                properties ancestral gene, represented the <br /> Role VEGF regulating survivin                            mouse, rationalizing use model elu- <br /> Vascular endothelial growth factor (VEGF) vasculo-         cidate role survivin health disease higher <br /> angiogenic, neurogenic, cardiogenic hematopoietic          animals. <br /> properties, effects endothelial cells mediated in <br /> part upregulating survivin [37]. Ma et al [16] demon-       While zebrafish survivin genes indistinguish- <br /> strated VEGF protein upregulates expression Birc5a     able patterns expression development, of <br /> in zebrafish 96 hpf. We evaluated VEGF        assays, hematopoiesis, depletion of <br /> rescue phenotypes induced depletion 2            Birc5a resulted severe, distinct <br /> zebrafish survivin genes. Human VEGF mRNA (500 pg)          phenotypes. For example, Birc5a depletion caused <br /> vehicle injected Tg(Fli:EGFP) embryos alone,       marked alterations ISV patterning. This phenotype <br /> with control morpholino, maximum dose mor-           readily attributed expression Birc5a at <br /> pholinos deplete Birc5a Birc5b (Figure 8).        somite boundaries, VEGF [39] guid- <br /> Embryos evaluated 2 dpf. In conjunction           ance molecules play crucial role vessel patterning <br /> Birc5a morpholino knockdowns (n = 86), VEGF mRNA               (reviewed [25]). However, Birc5b expressed in <br /> reduced incidence neural vascular defects        somites/somite boundaries, depletion no <br /> 43% 37%, respectively, observed Birc5a        effect ISVs. Thus, studies, including analy- <br /> morpholino alone. VEGF rescued phenotype              ses expression profiles relevant guidance mole- <br /> induced Birc5b depletion. Thus, administration           cules, required elucidate specific <br /> VEGF mRNA (n = 85) Birc5b morpholino decreased            properties Birc5 gene somites. <br /> the incidence vascular neural defects Birc5b mor- <br /> phants (n = 110), 20% 24%, respectively,        Functional differences Birc5 genes were <br /> found Birc5b morpholino alone. The results demon-         additionally uncovered titering respective mor- <br /> strate VEGF protect integrity neural       pholino doses evaluate effects paralog apop- <br /> and vascular systems single birc5 gene depletion,         tosis cell proliferation neural tube vascular <br /> possibly compensatory increase expression      structures. By approach, Birc5a more <br /> second birc5 gene.                                             effective protecting neural structures, Birc5b <br />                                                                effective protecting caudal vein plexus. <br /> Discussion conclusion                                      The interesting, caudal vein plexus is <br /> In attempting elucidate physiologic relevance    major site primitive hematopoiesis, process that <br /> inhibitor apoptosis protein, survivin, utilized     prominently disturbed Birc5b depletion. <br /> the zebrafish model characterized expression pat-      Nonetheless, administration mRNA effec- <br /> terns functions genes early development.     tively rescue phenotypes induced depletion the <br /> Our studies extend Ma et al [16],           other. Thus, physiologic relevance functional <br /> reported Birc5a angiogenic, vasculogenic,     differences survivin paralogs fully <br /> properties, discrepancy partly explained      delineated, appears act compen- <br /> the fact studies restricted developmental   sate deficiencies other. <br /> time points earlier 22 hpf. Several novel insights <br /> are provided work. Both Birc5a Birc5b           A common feature Birc5 genes, previously rec- <br /> expressed predominantly neural, vascular, ocular        ognized, expression somites axial <br /> structures, somites/somite boundaries;         vessels transient restricted early developmen- <br /> inhibit apoptosis promote cell proliferation;          tal time period, essentially gone 3 dpf. Up until <br /> both contribute normal vasculogenesis, angiogenesis,        time, axial vessels ISVs generated, and <br /> cardiogenesis, neurogenesis hematopoiesis. No        based morpholino knockdowns, survivin critical <br /> member IAP family shown simi-          formation structures, survivin is <br />  <br />                                                                                                                   Page 10 17 <br />                                                                                              (page number citation purposes) <br />  BMC Developmental Biology 2009, 9:25                                             http://www.biomedcentral.com/1471-213X/9/25 <br />  <br />  <br />  <br />  <br /> Figure <br /> Apoptosis6 Birc5-depleted embryos <br /> Apoptosis Birc5-depleted embryos. Tg(Fli:eGFP) embryos reveal apoptosis (red) relation blood vessels (green) (A- <br /> O). A-I: Morphants 1 dpf exhibit increased apoptosis, particularly brain (B) neural tube (E) Birc5a mor- <br /> phants (morpholino dose 2 ng). Birc5b depletion 4 ng morpholino caused apoptosis axial vessel region, caudal vein <br /> plexus, neural structures (C, F). G-I: Confocal microscopy 1 &#206;&#188;m sagittal &quot;slice&quot; region caudal vein plexus corre- <br /> sponding neural tube (excludes somites): Dose-dependent changes apoptosis caudal vein plexus region (J, region II) and <br /> corresponding neural tissue (J, region I) Birc5 knockdowns quantified 1 dpf. High dose Birc5a morpholino (2 ng) or <br /> Birc5b morpholino (4 ng) causes significant increase apoptosis caudal vein plexus neural tube (K, L). With lower Birc5a <br /> morpholino dose 0.5 ng), neural tube apoptosis remains significantly increased, absent caudal vein plexus (N). <br /> Low dose Birc5b morpholino (1.0 ng) causes significant apoptosis caudal vein plexus, neural tube (O). Data pre- <br /> sented panel. n = 30 &#195;&#8212; 3 independent experiments. * p &lt; 0.05 relative corresponding control. mhc: midbrain-hind- <br /> brain channel, aa: aortic arch, ax: axial vessels, cv: caudal vein plexus. <br />  <br />  <br />  <br />  <br />                                                                                                                        Page 11 17 <br />                                                                                                   (page number citation purposes) <br />  BMC Developmental Biology 2009, 9:25                                        http://www.biomedcentral.com/1471-213X/9/25 <br />  <br />  <br />  <br /> no longer necessary sites. Interestingly, IAP     gene, exogenous VEGF upregulated expression the <br /> Birc2 expressed vasculature zebrafish begin-      other, turn compensated phenotypic <br /> ning 54 hpf, required maintain           defects. In respect, Ma et al [37] indeed, demon- <br /> endothelial cell integrity [40]. One speculate      strated VEGF protein increase accumulation of <br /> there exists intrinsic molecular switch &quot;flipped&quot;   Birc5a mRNA zebrafish embryos. Beyond zebrafish <br /> at 2&#226;&#8364;&#8220;3 dpf, Birc5 expression turns off, Birc2         model system, upregulation survivin endothelial <br /> turns on, required form com-     cells well-documented [37]. The finding sur- <br /> plex vascular network. Characterization switch       vivin downstream effector VEGF neuro- <br /> mechanism enhance understanding reg-          logic system, survivin transcripts highly <br /> ulation angiogenesis.                                       expressed neural progenitor cells [50], implies the <br />                                                                survivin gene humans may, similar VEGF [51], a <br /> In mice depleted endothelial survivin, embryonic heart      modifier progression neural diseases, as <br /> development abnormal, mutant endocardial           amyotrophic lateral sclerosis, potential <br /> lineage cells support epithelial-mesenchymal         therapeutic target. <br /> transformation (EMT) [14]. In survivin gene knock- <br /> downs zebrafish, observed abnormalities      By regulating cell proliferation apoptosis, two <br /> cardiogenesis &#226;&#8364;&#8220; prominent Birc5a depletion.          zebrafish survivin genes, Birc5a Birc5b, play important <br /> Fate-mapping studies zebrafish revealed for-      roles multiple biologic systems. Although not <br /> mation atrium, ventricle a-v valves depends      examined organs development; yet <br /> the integrity cardiac neural crest cells [36],    evaluated role eye; prominent effects Birc5 <br /> intracardiac fluid forces contribute normal heart      gene depletion cardiac, neurovascular hemat- <br /> development [33]. Thus, etiology abnormalities      opoietic systems zebrafish embryo suggest sur- <br /> in cardiogenesis Birc5 morphants multifac-       vivin temporal tissue-specific properties. In view <br /> torial, i.e. secondary circulation defect and/or    apparent functional overlap murine and <br /> to loss cardiac neural crest cells. Further study    human survivin orthologues, zebrafish model pro- <br /> required elucidate relevant Birc5-dependent pro-        vides exceptional opportunity examine physio- <br /> survival pathways neural crest cells. Nonetheless,   logic relevance complex molecular biochemical <br /> the zebrafish mouse models highlight importance        pathways govern <span id='am-83' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-84' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-85' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-86' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-87' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-88' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-89' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-90' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-91' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-92' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-93' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-94' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-95' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-96' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-97' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-98' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-99' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-100' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-101' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-102' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-103' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-104' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-105' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-106' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-107' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-108' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-109' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-110' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-111' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-112' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-113' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-114' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-115' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-116' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-117' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-118' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-119' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-120' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-121' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-122' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-123' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-124' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-125' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-126' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-127' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-128' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-129' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-130' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-131' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-132' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-133' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-134' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-135' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-136' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-137' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-138' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-139' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-140' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-141' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-142' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-143' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-144' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-145' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-146' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-147' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-148' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-149' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-150' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-151' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-152' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-153' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-154' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-155' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-156' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-157' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-158' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-159' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-160' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span>cell survival</span> apoptosis. The <br /> of survivin heart development. Just single-nucleotide    insights gained lead development safer, tar- <br /> polymorphisms VEGF gene linked             geted therapeutics spectrum cardio-vascular, <br /> congenital valvuloseptal defects [41], possibility    hematopoeitic neurologic diseases, better <br /> functional alterations survivin expression under-     understanding etiology genetics array of <br /> lie congenital heart defects worthy consideration.       congenital diseases. <br />  <br /> The prominent role survivin plays regulating vas-      Methods <br /> culo-angiogenesis, neurogenesis, cardiogenesis             Zebrafish strains maintenance <br /> hematopoiesis supports widely accepted notion co-       Wild-type      AB     zebrafish         Tg(Flk1:EGFP), <br /> ordinately regulated development systems              Tg(Fli:EGFP)y1, Tg(gata1:GFP) zebrafish main- <br /> (reviewed [42]). For example, Eph/ephrins regulate      tained standard laboratory conditions [22]. <br /> fasciculation guidance axons, direct neural crest       Embryos grown 0.003% 1-phenyl-2-thiourea <br /> cell fate migration, modulate neural progenitor cell       (PTU, Sigma, Bornem, Belgium) 0.3&#195;&#8212; Danieau (17 mM <br /> survival, important cardiovascular        NaCl, 0.21 mM KCl, 0.12 mM MgSO4.7H2O, 0.18 <br /> development [43] erythropoiesis [44]. Vascular             mMCa(NO3)2, 1.5 mM Hepes (Fluka, Bornem, Belgium) <br /> endothelial growth factor (VEGF), best charac-        pH 7.6) starting 24 hpf, kept 28.5&#194;&#176;C, and <br /> terized critical mediator vasculogenesis angio-    staged according standard criteria [52]. After 24 hours, <br /> genesis, direct effects nervous         chorion removed trypsin 1.5 mg/ml (Sigma). <br /> (reviewed [45]). VEGF protects neural cells            All animal studies approved University Leu- <br /> hypoxia, facilitates axonal outgrowth, promotes endothe-       ven Animal Studies Ethics Commission. <br /> lial release neurogenic factors [46], induces neural <br /> stem cell proliferation [47]. VEGF promotes hemat-        Digoxigenin-labeled RNA probes situ hybridization <br /> opoiesis [48], altered regulation VEGF results       cDNAs cloned pGEM-T Easy vector (Promega, <br /> profound defects heart development [49]. These prop-        Leiden, Netherlands). For detection Birc5a, primer <br /> erties VEGF confirmed studies,         pairs: Birc5a-F1/R1, Birc5a-F2/R2 Birc5a-F3/R3 (see <br /> neural cardiovascular phenotypes induced deple-         Additional file 2) used generate amplicons, respec- <br /> tion Birc5a Birc5b, rescued VEGF. Although       tively, 902 bp (3&apos; coding region + UTR), 344 bp (only 3&apos; <br /> not tested, likely depletion Birc5      UTR) 429 bp (coding region). For detection Birc5b, <br />  <br />                                                                                                                   Page 12 17 <br />                                                                                              (page number citation purposes) <br />  BMC Developmental Biology 2009, 9:25                                              http://www.biomedcentral.com/1471-213X/9/25 <br />  <br />  <br />  <br />  <br /> Figure <br /> Cell proliferation <br />           7         Brc5-depleted embryos <br /> Cell proliferation Brc5-depleted embryos. Tg(Fli:eGFP) embryos, used localize proliferating cells (red, A-F) in <br /> relation blood vessels (green, A&apos;-F&apos;) Birc5 morpholino knockdowns. Proliferating cells immuno-detected whole- <br /> mount staining 2 dpf embryos anti-phospho-Histone H3 antibodies (red). The number proliferating cells caudal <br /> vein plexus neural tube (see Figure 6J regions) quantified embryos high dose (B, C) low dose (E, F) mor- <br /> pholino knockdowns. With high dose Birc5a Birc5b morpholino (2 ng 4 ng, respectively), significant decrease in <br /> cell proliferation caudal vein plexus neural tube (B, C) compared control (A). When Birc5a mor- <br /> pholino knockdown dose lowered (0.5 ng) (E), significant decrease cell proliferation neural tube, but <br /> not caudal vein plexus, compared control (D). Conversely, low dose Birc5b morpholino knockdown (1.0 ng) results in <br /> a significant diminution cell proliferation caudal vein plexus, neural tube (F). Quantitative data pre- <br /> sented panel. n = 30 &#195;&#8212; 3 independent experiments. * p &lt; 0.05 relative corresponding control. <br />  <br />  <br />  <br />  <br />                                                                                                                         Page 13 17 <br />                                                                                                    (page number citation purposes) <br />  BMC Developmental Biology 2009, 9:25                                                       http://www.biomedcentral.com/1471-213X/9/25 <br />  <br />  <br />  <br /> Table 1: Rescue neuro-vascular phenotypes Birc5 mRNAs <br />  <br />                                                                  Buffer Specific mRNA Co-injected <br />  <br />              Phenotype      Buffer         Birc5a mRNA                Birc5b mRNA                Birc5a mRNA                 Birc5b mRNA <br />                                               (n = 162)                  (n = 180)                  (n = 134)                   (n = 173) <br />  <br />  Birc5a kd      Neuro         61%                8%                         21% <br />                             (of 276) <br />  <br />               Vascular        40%               10%                         22% <br />                             (of 276) <br />  <br />  Birc5b kd      Neuro         26%                                                                      5%                           6% <br />                             (of 263) <br />  <br />               Vascular        38%                                                                      4%                           8% <br />                             (of 263) <br />  <br />  Birc5 morpholinos injected Tg(Fli:eGFP) zebrafish embryos simultaneously injections specific mRNAs shown, phenotypic <br />  analyses performed 2 dpf. The incidence neural vascular abnormalities illustrated. <br />  <br />  <br />  <br />  <br /> Figure of <br /> Rescue    8 Birc5 knockdown phenotypes VEGF mRNA <br /> Rescue Birc5 knockdown phenotypes VEGF mRNA. Birc5a Birc5b depleted 2 ng 4 ng, respec- <br /> tively, corresponding morpholino Tg(Fli:eGFP) embryos, human VEGF mRNA. Embryos evaluated at <br /> 2 dpf. Morpholino-induced angiogenic, cardiac neurodevelopmental defects reversed VEGF. <br />  <br />  <br />  <br /> probes following primer pairs: Birc5b-                  digested 0.05% trypsin/EDTA 15 minutes at <br /> F1/R1 Birc5b-F2/R2, generating amplicons, respec-                      28&#194;&#176;C. A single cell suspension obtained pipetting <br /> tively, 491 bp (coding region + 3&apos; UTR) 387 bp (cod-                down, 100% fetal calf serum (FCS) <br /> ing region). After linearization Spe1 Nco1,                       added. Cells filtered 40 &#206;&#188;M cell <br /> antisense riboprobes prepared DIG RNA                        strainer, washed 2% FCS/PBS, percentage of <br /> labeling kit (Roche, Vilvoorde, Belgium) according                  GFP-positive cells measured flow cytometry (Facs- <br /> manufacturer&apos;s instructions purified RNeasy                   Calibur, BD Biosciences). <br /> mini kit (Qiagen, Venlo, Netherlands). <br />                                                                            mRNA preparation <br /> Flow cytometry                                                             cDNAs plasmid vectors linearized appro- <br /> Tg(Gata1:GFP) zebrafish embryos injected 1-                    priate restriction enzyme, digested DNA eth- <br /> cell stage, 14 hpf, dechorionated                     anol precipitated. mRNA survivin gene transcript <br />  <br />                                                                                                                                    Page 14 17 <br />                                                                                                               (page number citation purposes) <br />  BMC Developmental Biology 2009, 9:25                                               http://www.biomedcentral.com/1471-213X/9/25 <br />  <br />  <br />  <br /> or vegf prepared according manufacturers           pretation data, writing manuscript. EC <br /> instructions (Ambion, Lennik, Belgium).                            conceived, designed co-ordinated project, and <br />                                                                    drafted manuscript. All authors read approved the <br /> Real-time PCR                                                      final manuscript. <br /> Quantitative real-time PCR performed examine the <br /> expression different hematopoietic genes using SYBR             Additional material <br /> green (Applied Biosystems, Belgium) according manu- <br /> facturers instructions. The sequence oligonucle- <br /> otide primers used reported Ma et al [29]. The &#206;&#178;-         Additional file 1 <br />                                                                     Survivin orthologues. <br /> actin mRNA levels used internal reference.               A. Using CLUSTAL W program, protein sequences human, <br />                                                                     mouse, Xenopus zebrafish survivin aligned.B. The overall <br /> Morpholino mRNA injection                                       similarity (in %) level amino acid sequence survivins of <br /> Morpholinos (Gene Tools LLC, Oregon, USA) tar-                 human, mouse, Xenopus zebrafish compared. Homo, Homo <br /> geted ATG 5&apos;UTR Birc5a Birc5b. Mor-           sapiens; Mus, Mus musculus; XT, Xenopus tropicalis; Birc5, danio <br />                                                                     rerio; XL, Xenopus laevis; * identical amino acid; conserved change; <br /> pholinos synthetic mRNAs diluted 1.5% <br />                                                                     highly conserved change. <br /> phenol red (Sigma) 0.2 M KC. Fertilized zebrafish eggs           Click file <br /> at 1&#226;&#8364;&#8220;4 cell stage positioned agar slots,          [http://www.biomedcentral.com/content/supplementary/1471- <br /> using Femtojet (Eppendorf, Haasrode, Belgium),                  213X-9-25-S1.ppt] <br /> micromanipulator (Narishige, New York, USA) a <br /> Zeiss-stemi 2000-C light microscope (Zeiss, Zaventum,               Additional file 2 <br /> Belgium), eggs injected 1 nl morpholino                Supplementary table 1. <br /> using back-filled fine borosilicate, glass capillary needles.       Primers used generate situ hybridization probes. <br />                                                                     Click file <br />                                                                     [http://www.biomedcentral.com/content/supplementary/1471- <br /> Detection apoptosis cell proliferation                       213X-9-25-S2.rtf] <br /> Embryos fixed 4% paraformaldehyde overnight at <br /> 4&#194;&#176;C stored methanol -20&#194;&#176;C processing.       Additional file 3 <br /> In situ hybridization performed described [17]. For          Supplementary table 2. <br /> apoptosis cell proliferation studies, embryos        Morpholinos used knockdown Birc5a Birc5b. <br /> rehydrated decreasing concentrations methanol,              Click file <br />                                                                     [http://www.biomedcentral.com/content/supplementary/1471- <br /> washed PBST (PBS, 0.1% Tween 20), treated protei- <br />                                                                     213X-9-25-S3.rtf] <br /> nase K (10 mg/ml) 37&#194;&#176;C 30 60 minutes, refixed with <br /> 4% paraformaldehyde, washed PBST, lastly incubated           Additional file 4 <br /> with 0.1 M citrate solution (0.1% citrate/PBS/Triton). TUNEL        Specificity Birc5 morpholinos. <br /> staining performed ApopTag kit (Chemicon,              An oligonucleotide zebrafish survivingene containing the <br /> Heule, Belgium). Cell proliferation visualized using anti-      binding sites different morpholinos directed 5&apos; UTR <br /> bodies phosphorylated phospho-histone H3 (Upstate,          ATG gene, cloned pCAG-T7-luciferase <br />                                                                     plasmid, resulting pCAG-T7-luciferase-Birc5a pCAG-T7- <br /> Huissen, Netherlands). After mounting 3% methylcel- <br />                                                                     luciferase-Birc5b plasmids. These plasmids, varying doses <br /> lulose (Sigma) PBS, embryos visualized light             Birc5 morpholinos, used in vitrotranscription/translation <br /> microscopy Zeiss Lumar fluorescence stereomicro-          assay, described [18]. Experiments performed triplicate. Luci- <br /> scope, pictures taken green fluorescence             ferase activity measured arbitrary light units noted the <br /> Tg(Fli:eGFP) red fluorescence (apoptotic cells prolifer-     Y-axis. Birc5a depleted Birc5a morpholino (B-F) not <br /> ating cells) Zeiss AxioCam MRc digital camera. For      Birc5b morpholino (G-K). Similarly, Birc5b depleted the <br />                                                                     Birc5b morpholino (R-V) Birc5a morpholino (M-Q). <br /> embryo, entire caudal vein plexus corresponding over- <br />                                                                     Birc5a plasmid: pCAG-T7-luciferase-Birc5a; Birc5b plasmid: pCAG-T7- <br /> lying neural tube delineated, apoptotic cells prolif-    luciferase-Birc5b; MO1: Birc5a morpholino; MO2: Birc5b morpholino. <br /> erating cells manually counted. 30 embryos                Click file <br /> analyzed condition 3 experiments performed.            [http://www.biomedcentral.com/content/supplementary/1471- <br /> Data compared standard Student t-test.                  213X-9-25-S4.ppt] <br />  <br />  <br /> Authors&apos; contributions                                              Additional file 5 <br />                                                                     Tg(Flk1:GFP) control-injected embryo 3 dpf. <br /> MD FZ carried situ hybridizations micros- <br />                                                                     Confocal microscopy used visualize cross sectional view from <br /> copy, designed experiments, MD drafted               head region 3 dpf zebrafish embryo, revealing the <br /> the manuscript. AD, IB MM prepared riboprobes,              different vascular structures. <br /> did cDNA cloning sequencing, helped situ            Click file <br /> hybridizations, acquisition data analyses. MA pro-           [http://www.biomedcentral.com/content/supplementary/1471- <br /> vided continuous intellectual input, evaluation inter-          213X-9-25-S5.mov] <br />  <br />  <br />  <br />                                                                                                                               Page 15 17 <br />                                                                                                         (page number citation purposes) <br />  BMC Developmental Biology 2009, 9:25                                                             http://www.biomedcentral.com/1471-213X/9/25 <br />  <br />  <br />  <br />                                                                                       Molecular mechanisms hypoxia-induced upregulation. Am <br />      Additional file 6                                                                J Pathol 2003, 163:935-946. <br />                                                                                 13.   Jiang Y, Bruin A, Caldas H, Fangusaro J, Hayes J, Conway EM, Rob- <br />      Tg(Flk1:GFP) Birc5a morphant embryo 3 dpf.                                    inson M, Altura RA: Essential role survivin early brain <br />      When compared control (Movie S1), depletion Birc5a                development. J Neurosci 2005, 25:6962-70. <br />      2 ng morpholino results striking underdevelopment irregu-        14.   Zwerts F, Lupu F, De Vriese A, Pollefeyt S, Moons L, Altura RA, Jiang <br />      lar patterning blood vessels head embryo.               Y, Maxwell PH, Hill P, Oh H, et al.: Lack endothelial cell sur- <br />      Click file                                                              vivin causes embryonic defects angiogenesis, cardiogen- <br />                                                                                       esis, neural tube closure. Blood 2007, 109:4742-52. <br />      [http://www.biomedcentral.com/content/supplementary/1471-                  15.   Du Pasquier D, Phung AC, Ymlahi-Ouazzani Q, Sinzelle L, Ballagny C, <br />      213X-9-25-S6.mov]                                                                Bronchain O, Du Pasquier L, Mazabraud A: Survivin increased vas- <br />                                                                                       cular development Xenopus ontogenesis. Differentia- <br />      Additional file 7                                                                tion 2006, 74:244-53. <br />                                                                                 16.   Ma A, Lin R, Chan PK, Leung JC, Chan LY, Meng A, Verfaillie CM, <br />      Tg(Flk1:GFP) Birc5b morphant embryo 3 dpf.                                    Liang R, Leung AY: The role survivin angiogenesis during <br />      When compared control (Movie S1), knockdown Birc5b                zebrafish embryonic development. BMC Dev Biol 2007, 7:50. <br />      4 ng morpholino leads underdevelopment vascular structures        17.   Hauptmann G, Gerster T: Two-color whole-mount situ <br />      head, lesser extent Birc5a morphants            hybridization vertebrate Drosophila embryos. Trends <br />      (Movie S2).                                                                      Genet 1994, 10:266. <br />                                                                                 18.   Ny A, Koch M, Schneider M, Neven E, Tong RT, Maity S, Fischer C, <br />      Click file                                                              Plaisance S, Lambrechts D, Heligon C, et al.: A genetic Xenopus <br />      [http://www.biomedcentral.com/content/supplementary/1471-                        laevis tadpole model study lymphangiogenesis. Nat Med <br />      213X-9-25-S7.mov]                                                                2005, 11:998-1004. <br />                                                                                 19.   Robu ME, Larson JD, Nasevicius A, Beiraghi S, Brenner C, Farber SA, <br />                                                                                       Ekker SC: p53 activation knockdown technologies. PLoS <br />                                                                                       Genet 2007, 3:e78. <br />                                                                                 20.   Koster RW, Fraser SE: FGF signaling mediates regeneration of <br /> Acknowledgements                                                                      differentiating cerebellum repatterning the <br />                                                                                       anterior hindbrain reinitiation neuronal migration. J <br /> This work supported Fonds voor Wetenschappelijk <br />                                                                                       Neurosci 2006, 26:7293-304. <br /> Onderzoek (FWO), Belgium. We thank Lieve Moons Filip Claes              21.   Appel B, Korzh V, Glasgow E, Thor S, Edlund T, Dawid IB, Eisen JS: <br /> their advice.                                                                         Motoneuron fate specification revealed patterned LIM <br />                                                                                       homeobox gene expression embryonic zebrafish. Develop- <br />                                                                                       ment 1995, 121:4117-25. <br /> References                                                                      22.   Lawson ND, Weinstein BM: In vivo imaging embryonic vascu- <br /> 1.      Schimmer AD: Inhibitor apoptosis proteins: translating                     lar development using transgenic zebrafish. Dev Biol 2002, <br />         basic knowledge clinical practice. Cancer Res 2004,                      248:307-18. <br />         64:7183-90.                                                             23.   Fouquet B, Weinstein BM, Serluca FC, Fishman MC: Vessel <span id='am-239' about='xsp:pattern' typeof='owl:Thing'>pattern</span>- <br /> 2.      Ambrosini G, Adida C, Altieri D: A novel anti-apoptosis gene,                 ing embryo zebrafish: guidance notochord. <br />         survivin, expressed cancer lymphoma. Nature Medicine                   Dev Biol 1997, 183:37-48. <br />         1997, 3:917-921.                                                        24.   Zhong TP: Zebrafish genetics formation embryonic <br /> 3.      Uren AG, Wong L, Pakusch M, Fowler KJ, Burrows FJ, Vaux DL,                   vasculature. Curr Top Dev Biol 2005, 71:53-81. <br />         Choo KH: Survivin inner centromere protein                      25.   Baldessari D, Mione M: How create vascular tree? (Lat- <br />         INCENP similar cell-cycle localization gene knock-                   est) help zebrafish. Pharmacol Ther 2008, 118:206-30. <br />         phenotype. Curr Biol 2000, 10:1319-28.                              26.   Rubinstein AL, Lee D, Luo R, Henion PD, Halpern ME: Genes <br /> 4.      Suzuki A, Ito T, Kawano H, Hayashida M, Hayasaki Y, Tsutomi Y, Aka-           dependent zebrafish cyclops function identified AFLP <br />         hane K, Nakano T, Miura M, Shiraki K: Survivin initiates procas-              differential gene expression screen. Genesis 2000, 26:86-97. <br />         pase 3/p21 complex formation result interaction            27.   Snider P, Olaopa M, Firulli AB, Conway SJ: Cardiovascular devel- <br />         Cdk4 resist Fas-mediated cell death. Oncogene 2000,                        opment colonizing cardiac neural crest lineage. Sci- <br />         19:1346-53.                                                                   entificWorldJournal 2007, 7:1090-113. <br /> 5.      Adida C, Crotty P, McGrath J, Berrebi D, Diebold J, Altieri D: Devel-   28.   Vogeli KM, Jin SW, Martin GR, Stainier DY: A common progenitor <br />         opmentally regulated expression novel cancer anti-                     haematopoietic endothelial lineages zebrafish <br />         apoptosis gene survivin human mouse differentiation.                   gastrula. Nature 2006, 443:337-9. <br />         Am J Path 1998, 152:43-49.                                              29.   Ma AC, Liang R, Leung AY: The role phospholipase C gamma <br /> 6.      Fukuda S, Pelus LM: Survivin, cancer target emerging                1 primitive hematopoiesis zebrafish development. <br />         role normal adult tissues. Mol Cancer Ther 2006, 5:1087-98.                Exp Hematol 2007, 35:368-73. <br /> 7.      Altieri DC: New wirings survivin networks. Oncogene              30.   Yelon D, Horne SA, Stainier DY: Restricted expression cardiac <br />         2008, 27:6276-84.                                                             myosin genes reveals regulated aspects heart tube assem- <br /> 8.      Li F, Ling X: Survivin study: update &quot;what                  bly zebrafish. Dev Biol 1999, 214:23-37. <br />         wave&quot;? J Cell Physiol 2006, 208:476-86.                                 31.   Chen JN, van Eeden FJ, Warren KS, Chin A, Nusslein-Volhard C, <br /> 9.      Altznauer F, Martinelli S, Yousefi S, Thurig C, Schmid I, Conway E,           Haffter P, Fishman MC: Left-right pattern cardiac BMP4 may <br />         Schoni M, Vogt P, Mueller C, Fey M, et al.: Inflammation-associ-              drive asymmetry heart zebrafish. Development 1997, <br />         ated cell cycle-independent block apoptosis survivin                 124:4373-82. <br />         terminally differentiated neutrophils.           J Exp Med 2004,        32.   Glickman NS, Yelon D: Cardiac development zebrafish: coor- <br />         199:1343-54.                                                                  dination form function. Semin Cell Dev Biol 2002, <br /> 10.     Conway EM, Pollefeyt S, Steiner-Mosonyi M, Luo W, DeVriese A,                 13:507-13. <br />         Lupu F, Bono F, Leducq N, Dol F, Schaeffer P, et al.: Deficiency     33.   Hove JR, Koster RW, Forouhar AS, Acevedo-Bolton G, Fraser SE, <br />         Survivin Transgenic Mice Exacerbates Fas-Induced Apop-                     Gharib M: Intracardiac fluid forces essential epigenetic <br />         tosis Mitochondrial Pathways.             Gastroenterology 2002,          factor embryonic cardiogenesis. Nature 2003, 421:172-7. <br />         123:619-631.                                                            34.   Li YX, Zdanowicz M, Young L, Kumiski D, Leatherbury L, Kirby ML: <br /> 11.     Leung CG, Xu Y, Mularski B, Liu H, Gurbuxani S, Crispino JD:                  Cardiac neural crest zebrafish embryos contributes to <br />         Requirements survivin terminal differentiation                      myocardial cell lineage early heart function. Dev Dyn <br />         erythroid cells maintenance hematopoietic stem                     2003, 226:540-50. <br />         progenitor cells. J Exp Med 2007, 204:1603-11.                          35.   Lister JA, Cooper C, Nguyen K, Modrell M, Grant K, Raible DW: <br /> 12.     Conway EM, Zwerts F, Van Eygen V, DeVries A, Nagai N, <br /> </body></html>